MBMikhail V. Belyakov

Mikhail V. Belyakov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikhail V. Belyakov has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Characteristics of the Fatty Acid Composition in Elderly Patients with Occupational Pathology from Organophosphate Exposure

    by Nikolay V. Goncharov, Elena I. Savelieva, Tatiana A. Koneva, Lyudmila K. Gustyleva, Irina A. Vasilieva, Mikhail V. Belyakov, Natalia G. Voitenko, Daria A. Belinskaia, Ekaterina A. Korf, Richard O. Jenkins

    Background/Objectives: The delayed effects of organophosphate poisoning may manifest years after exposure, often masked by age-related diseases. The aim of this retrospective cohort study was to identify the biochemical “trace” that could remain in patients decades after poisoning. We determined a wide range of biochemical parameters, along with the spectrum of esterified and non-esterified fatty acids (EFAs and NEFAs, respectively), in the blood plasma of a cohort of elderly patients diagnosed with occupational pathology (OP) due to (sub)chronic exposure to organophosphates in the 1980s. Methods: Elderly patients with and without a history of exposure to organophosphates were retrospectively divided into two groups: controls (n = 59, aged 73 ± 4, men 29% and women 71%) and those with OP (n = 84, aged 74 ± 4, men 29% and women 71%). The period of neurological examination and blood sampling for subsequent analysis was from mid-2022 to the end of 2023. Determination of the content of biomarkers of metabolic syndrome, NEFAs, and EFAs in blood plasma was performed by HPLC-MS/MS and GC-MS. Results: The medical histories of the examined elderly individuals with OP and the aged control group included common age-related diseases. However, patients with OP more often had hepatitis, gastrointestinal diseases, polyneuropathy, and an increased BMI. Analysis of metabolic biomarkers revealed, in the OP group, a decrease in the concentrations of 3-hydroxybutyrate (p < 0.05), 2-hydroxybutyrate (p < 0.0001), and acetyl-L-carnitine (p < 0.001) and the activity of butyrylcholinesterase (BChE) (p < 0.05), but an increase in the esterase activity of albumin (p < 0.05). Correlation analysis revealed significant relationships between albumin esterase activity and arachidonic acid concentrations in the OP group (0.64, p < 0.0001). A study of a wide range of fatty acids in patients with OP revealed reciprocal relationships between EFAs and NEFAs. A statistically significant decrease in concentration was shown for esters of margaric, stearic, eicosadienoic, eicosatrienoic, arachidonic, eicosapentaenoic, and docosahexaenoic fatty acids. A statistically significant increase in concentration was shown for non-esterified heptadecenoic, eicosapentaenoic, eicosatrienoic, docosahexaenoic, γ-linolenic, myristic, eicosenoic, arachidonic, eicosadienoic, oleic, linoleic, palmitic, linoelaidic, stearic, palmitoleic, pentadecanoic, and margaric acids. Decreases in the ratios of omega-3 to other unsaturated fatty acids were observed only for the esterified forms. Conclusions: The data obtained allow us to consider an increased level of NEFAs as one of the main cytotoxic factors for the vascular endothelium. Modification of albumin properties and decreased bioavailability of docosahexaenoic acid could be molecular links that cause specific manifestations of organophosphate-induced pathology at late stages after exposure.


  • Open Access

    Characteristics of the Fatty Acid Composition in Elderly Patients with Occupational Pathology from Organophosphate Exposure

    by Nikolay V. Goncharov, Elena I. Savelieva, Tatiana A. Koneva, Lyudmila K. Gustyleva, Irina A. Vasilieva, Mikhail V. Belyakov, Natalia G. Voitenko, Daria A. Belinskaia, Ekaterina A. Korf, Richard O. Jenkins

    Background/Objectives: The delayed effects of subchronic and chronic organophosphate poisoning may manifest years after exposure, often masked by age-related diseases. The aim of this retrospective cohort study was to identify the biochemical "trace" that could remain in the patients decades after the poisoning. To achieve this goal, we determined a wide range of biochemical parameters, along with the spectrum of esterified and non-esterified fatty acids (EFA and NEFA, respectively), in the blood plasma of a cohort of elderly patients diagnosed with occupational pathology (OP) due to subacute or (sub)chronic exposure to organophosphates in the 1980s. Methods: Elderly patients with and without a history of exposure to organophosphates were retrospectively divided into two groups: controls (n=59, aged 73±4, men 29% and women 71%) and having the OP (n=84, aged 74±4, men 29% and women 71%). The period of neurological examination and blood sampling for subsequent analysis was approximately one and a half years - from mid-2022 to the end of 2023. Determination of the content of biomarkers of metabolic syndrome, NEFA and EFA in blood plasma was performed by HPLC-MS/MS and GC-MS. Results: The medical history of the examined elderly individuals with OP and the aged control group includes common age-related diseases. However, patients with OP more often have hepatitis (33 vs 7%, p<0.001) and other gastrointestinal diseases (54 vs 32%, p<0.05), total with diagnosis of polyneuropathy (87 vs 66%, p<0.01) and polyneuropathy of the upper and lower extremities (29 vs 12%, p<0.05), impaired distal sensitivity (83 vs 56%, p<0.001), increased body mass index (30.0±4.6 vs 28.4±4.1, p<0.05), and also they have an increased drug load (5 vs 4, p<0.001). Patients with OP more often have balance problems (84 vs 69%, p<0.05) and difficulties in performing daily activities (75 vs 49%, p<0.01). No differences were found between the groups when assessing cognitive function using the MMSE (mini mental state examination), SAGE (self-administered gerocognitive exam), and “Clock” tests. Of the 34 basic biochemical parameters determined on the biochemical analyzer, statistically significant changes were found for only 11, with their median values not going beyond the reference range (clinical norm), and the differences being due to significant individual deviations. Analysis of some metabolic biomarkers with HPLC-MS/MS revealed in the OP group a 1.4-fold decrease in the concentration of 3-hydroxybutyrate (p<0.05, AUC=0.62) and 1.6-fold decrease in the concentration of 2-hydroxybutyrate (p<0.0001, AUC=0.72). In the OP group, a 26% decrease in acetyl-L-carnitine concentration was found (p<0.001, AUC=0.69). An additional study of the esterase profile of patients revealed a decrease in the activity of butyrylcholinesterase (BChE) by 14% (p<0.05, AUC=0.62) though increase in the esterase activity of albumin by 29% (p<0.05, AUC=0.62) in the OP group. Correlation analysis revealed the most significant relationships between albumin esterase activity and arachidonic acid concentration in the OP group (0.64, p<0.0001). A study of a wide range of fatty acids in patients with OP revealed reciprocal relationships between EFA and NEFA. A decrease in concentration was shown for esters of margaric (p<0.01, AUC=0.65), stearic (p<0.01, AUC=0.65), eicosadienoic (p<0.01, AUC=0.63), eicosatrienoic (p<0.01, AUC=0.66), arachidonic (p<0.001, AUC=0.67), eicosapentaenoic (p<0.05, AUC=0.60), and docosahexaenoic (p<0.0001, AUC=0.74) fatty acids. An increase in the concentration was shown for free (non-esterified) fatty acids: heptadecenoic (p<0.0001, AUC=0.72), eicosapentaenoic (p<0.05, AUC=0.62), eicosatrienoic (p<0.001, AUC=0.68), docosahexaenoic (p<0.01, AUC=0.66), γ-linolenic (p<0.01, AUC=0.66), myristic (p<0.0001, AUC=0.71), eicosenoic (p<0.01, AUC=0.65), arachidonic (p<0.01, AUC=0.66), eicosadienoic (p<0.001, AUC=0.67), oleic (p<0.01, AUC=0.66), linoleic (p<0.01, AUC=0.65), palmitic (p<0.001, AUC=0.68), linoelaidic (p<0.01, AUC=0.65), stearic (p<0.01, AUC=0.64), palmitoleic (p<0.05, AUC=0.61), pentadecanoic (p<0.05, AUC=0.61), and margaric (p<0.01, AUC=0.64). Decrease in the ratios of omega-3 to other unsaturated fatty acids were observed only for the esterified forms: by 29% for n3/n6 (p<0.0001, AUC=0.70), by 33% for n3/(n6+n9) (p<0.0001, AUC=0.72), and by 26% for n3/(all fatty acids) (p<0.0001, AUC=0.72). Finally, we have found out how the most reliable indicators correlate with each other. The esterified docosahexaenoic acid – lactate dehydrogenase (LDH) (0.67, p <0.0001) and LDH – total antioxidant status (TAS) (-0.61, p <0.0001) correlations are stronger in the OP group compared to the correlation in the overall sample and lose their strength and statistical significance in the control group. In the OP group, esterified docosahexaenoic fatty acid, LDH activity, and TAS concentration have a moderate correlation with calcium concentration (-0.66, p <0.0001; -0.67, p <0.0001; 0.63, p <0.0001, respectively). In the control group, this correlation is significantly weakened. Esterified docosahexaenoic acid in the OP group also demonstrated strong positive correlations with a row of other esterified fatty acids, though these correlations were not significantly weakened in the control group. Conclusions: The data obtained allow us to consider an increased level of NEFA as one of the main cytotoxic factors for the vascular endothelium, which can determine the specificity of age-related diseases. Modification of albumin properties by arachidonic acid decreased bioavailability of docosahexaenoic acid could be molecular links that cause specific manifestations of OP-induced pathology at late stages after exposure. Epigenetic changes, the contribution of...


  • Open Access

    Light induces a rapid increase in cAMP and activates PKA in rod outer segments of the frog retina

    by Olga Chernyshkova, Natalia Erofeeva, Darya Meshalkina, Anna Balykina, Stepan Gambaryan, Michael Belyakov, Michael Firsov

    The phototransduction cascade enables the photoreceptor to detect light over a wide range of intensities without saturation. The main second messenger of the cascade is cGMP and the primary regulatory mechanism is calcium feedback. However, some experimental data suggest that cAMP may also play a role in regulating the phototransduction cascade, but this would require changes in cAMP on a time scale of seconds. Currently, there is a lack of data on the dynamics of changes in intracellular cAMP levels on this timescale. This is largely due to the specificity of the sensory modality of photoreceptors, which makes it practically impossible to use conventional experimental approaches based on fluorescence methods. In this study, we employed the method of rapid cryofixation of retinal samples after light stimulation and subsequent isolation of outer segment preparations. The study employed highly sensitive metabolomics approaches to measure levels of cAMP. Additionally, PKA activity was measured in the samples using a western blot. The results indicate that when exposed to near-saturating but still moderate light, cAMP levels increase transiently within the first second and then return to pre-stimulus levels. The increase in cAMP activates PKA, resulting in the phosphorylation of PKA-specific substrates in frog retinal outer segments.


  • Open Access

    Antiplatelet Effects of Flavonoid Aglycones Are Mediated by Activation of Cyclic Nucleotide-Dependent Protein Kinases

    by Anna Balykina, Lidia Naida, Kürsat Kirkgöz, Viacheslav O. Nikolaev, Ekaterina Fock, Michael Belyakov, Anastasiia Whaley, Andrei Whaley, Valentina Shpakova, Natalia Rukoyatkina, et al.

    Flavonoid aglycones are secondary plant metabolites that exhibit a broad spectrum of pharmacological activities, including anti-inflammatory, antioxidant, anticancer, and antiplatelet effects. However, the precise molecular mechanisms underlying their inhibitory effect on platelet activation remain poorly understood. In this study, we applied flow cytometry to analyze the effects of six flavonoid aglycones (luteolin, myricetin, quercetin, eriodictyol, kaempferol, and apigenin) on platelet activation, phosphatidylserine externalization, formation of reactive oxygen species, and intracellular esterase activity. We found that these compounds significantly inhibit thrombin-induced platelet activation and decrease formation of reactive oxygen species in activated platelets. The tested aglycones did not affect platelet viability, apoptosis induction, or procoagulant platelet formation. Notably, luteolin, myricetin, quercetin, and apigenin increased thrombin-induced thromboxane synthase activity, which was analyzed by a spectrofluorimetric method. Our results obtained from Western blot analysis and liquid chromatography–tandem mass spectrometry demonstrated that the antiplatelet properties of the studied phytochemicals are mediated by activation of cyclic nucleotide-dependent signaling pathways. Specifically, we established by using Förster resonance energy transfer that the molecular mechanisms are, at least partly, associated with the inhibition of phosphodiesterases 2 and/or 5. These findings underscore the therapeutic potential of flavonoid aglycones for clinical application as antiplatelet agents.


    • 1 January 2015
      • Vol. 28  (4) , 629-633

    [Influence of changes in the reproductive behavior on the average duration of the reproductive period and life span].

    by M V Belyakov

    This article explains the model of changing the duration of the reproductive period and life span under the influence of the demographic trend towards an increase in age at first birth in modern developed countries. Acting as a factor of artificial selection, increase parental age may lead to a shift of the upper boundary of the reproductive period in the new generations, and life expectancy. The article discusses the role of a number of social factors to identify trends.